Here's why Lupin, Aurobindo, Titan stocks are in limelight

Stocks likely to be limelight are:Drug major Lupin has received US health regulator's approval to market Fyavolv tablets, used to treat postmenopausal osteoporosis, in the American market. The company has received received the final approval from the United States Food and Drug Administration (FDA) to market Fyavolv tablets, Lupin today said in a statement. "Lupin's US subsidiary, Lupin Pharmaceuticals Inc shall commence promoting the product in the US shortly," it added.

The company's product is the generic equivalent of Warner Chilcott's Femhrt tablets, which are indicated for the treatment of moderate to severe vasomotor symptoms due to menopause and prevention of postmenopausal osteoporosis. According to IMS MAT September data, Femhrt had US sales of USD 39.9 million. The Mumbai-based firm has launched eight products in the US this fiscal and received approvals for 19 from the FDA.Aurobindo Pharma gets tentative US FDA nod for Esomeprazole Magnesium or for Nexium generic. Nexium generic is used to treat gastric ulcers. Nexium generic market size at USD 1.8-2 billion. Nexium generic is a 5-6 player market currently. Tentative nod positive for company, will only be able to launch Nexium generic once it receives final approval. Newspaper reports Blackstone, Birla Corp and Baring Asia potential buyers for company's cement business. Blackstone was most aggressive bidder for company's cement business. Most offers for cement business at a valuation of Rs 4,000-4,200 crore. Offers for cement business below expected valuation of Rs 5,000 crore. Sources suggest highest offer exceeded value expectation. Company's consolidated debt nearly Rs 24,645 crore as of September 2015.Titan management says festive season had a mixed response from customers in third quarter. Watches & eyewear categories did not see expected traction in third quarter. Fin Min's new PAN Card norms may have some impact on cash sales. Festive season has been a washout in Tamil Nadu.NBCC wins contract worth Rs 328 crore. Contract for construction of township project from Nabinagar Power Generating Company. Nabinagar Power is a JV between NTPC & Bihar State Power Generation. Fourth order win for the company in December. Total orderbook at nearly Rs 33,300 crore. Management had guided for orderbook of Rs 40,000 crore by March 2016. Blended margins for FY16 at 7-8 percent. New order can add Rs 21 cr to company's profit over executable period.Educomp Solutions arm, Educomp Infra & School Management to sell its land & building to third party. Educomp Infra to make an announcement on deal completion.L&T Infotech reports indicate to raise Rs 2,000 crore via IPO. IPO planned in Q4FY16. DRHP filed with SEBI in September. IPO comprises of an offer for sale of upto 1.75 crore shares with Face Value of Re 1.JBF Industries to issue 1.63 crore shares on preferential basis to KKR Jupiter Investors. Preferential shares to be issued at Rs 300/share (21 percent premium to CMP). Move valued at Rs 489 crore.Sterlite Grid has emerged as the lowest bidder for a Rs 1,500-crore transmission project in Odisha by quoting a lowest annual tariff of Rs 139.79 crore."For Common Transmission System for Phase-II Generation Projects in Odisha and Immediate Evacuation System for OPGC Project in Odisha, Sterlite Grid has emerged as the lowest bidder followed by Essel and Adani," a source said. Sterlite Grid is a Vedanta group firm. JSPL approved SDR scheme to lenders of Jindal Power. SDR: strategic debt restructuring. Jindal Power's 'Phase III' 1200 MW power project situated at Tamnar. Nod for conversion of loan into equity share capital of JPL in event of default.The other stocks in limelight are GSPL and Arvind.